Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation-Reference-Cited by-同舟云学术

Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation

Published:2018-10-05 Issue:6 Volume:1 Page:e182311
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Streja Elani¹²,Gosmanova Elvira O.³⁴,Molnar Miklos Z.⁵⁶⁷⁸,Soohoo Melissa¹²,Moradi Hamid¹²,Potukuchi Praveen K.⁸,Kalantar-Zadeh Kamyar¹²,Kovesdy Csaba P.⁸⁹

Affiliation:

1. Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, Department of Medicine, University of California Irvine Medical Center, Orange

2. Nephrology Section, Tibor Rubin Veterans Affairs Medical Center, Long Beach, California

3. Nephrology Section, Stratton Veterans Affairs Medical Center, Albany, New York

4. Division of Nephrology, Department of Medicine, Albany Medical College, Albany, New York

5. Division of Transplant Surgery, Methodist University Hospital Transplant Institute, Memphis, Tennessee

6. Department of Surgery, University of Tennessee Health Science Center, Memphis

7. Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary

8. Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis

9. Nephrology Section, Memphis Veterans Affairs Medical Center, Memphis, Tennessee

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/1/6/e182311/17300617/streja_2018_oi_180122.pdf

Reference44 articles.

1. KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.;Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group;Kidney Int Suppl,2013

2. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.;Baigent;Lancet,2011

3. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.;Herrington;Lancet Diabetes Endocrinol,2016

4. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) trial.;Ridker;J Am Coll Cardiol,2010

5. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.;Sever;Lancet,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation versus continuation of statins: A systematic review;Journal of the American Geriatrics Society;2024-07-25

2. Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path;Reviews in Cardiovascular Medicine;2024-06-25

3. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association;Circulation;2023-11-14

4. Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview;Diabetes & Metabolism Journal;2023-09-30

5. Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases;Scientific Reports;2023-07-06